Skip to main content
Premium Trial:

Request an Annual Quote

Duke and Ardais Establish Biorepository for Cancer Programs

NEW YORK, April 19 (GenomeWeb News) - Ardais and the DukeUniversityMedicalCenterannounced today that they have established a biorepository, based on Ardais' Biospecimen Management System, to support Duke's cancer programs.


The biorepository will encompass, according to the involved parties: institution-wide collection and archiving of samples and data; ethics-based protocols for collection, processing, archiving and dissemination; IT capabilities for processing large volumes of clinical data; and the ability to network with other cancer centers and drug developers in the future with which the institutions may develop future alliances. It will provide human biomaterials and clinical data for research.


The biorepository is the result of a biomaterials initiative that Duke and Ardais began four years ago.


The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.